Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

348 ARTÍCULOS , VIENDO DEL 31 AL 45

Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer's Disease

Boccardi V, Ruggiero C, Patriti A, Marano L.

J Alzheimers Dis. 2016;50(4):947-55. doi: 10.3233/JAD-150931.

Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation

Smith R, Wibom M, Olsson T, Hägerström D, Jögi J, Rabinovici GD, Hansson O.

J Alzheimers Dis. 2016;51(2):339-43. doi: 10.3233/JAD-151004.

Gray matter volumes and treatment response of psychotic symptoms to risperidone in antipsychotic-naïve Alzheimer's disease patients

Lee YM, Park JM, Lee BD, Moon E, Jeong HJ, Chung YI, Kim JH, Kim HJ, Mun CW, Kim TH, Kim YH.

J Clin Psychiatry. 2016 Jan;77(1):e8-13. doi: 10.4088/JCP.14m09740.

Nano-biosensors to detect beta-amyloid for Alzheimer's disease management

Kaushik A, Jayant RD, Tiwari S, Vashist A, Nair M.

Biosens Bioelectron. 2016 Jun 15;80:273-287. doi: 10.1016/j.bios.2016.01.065. Epub 2016 Jan 28.

Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET

van Westen D, Lindqvist D, Blennow K, Minthon L, Nägga K, Stomrud E, Zetterberg H, Hansson O.

Sci Rep. 2016 Feb 9;6:20709. doi: 10.1038/srep20709.

Visual function alterations in Alzheimer Disease: A case report

Pablo Piñero D, Monllor B, Moncho V, de Fez D.

Can J Ophthalmol. 2016 Feb;51(1):e16-8. doi: 10.1016/j.jcjo.2015.09.009.

Apolipoprotein E (APOE) ε4 and episodic memory decline in Alzheimer's disease: A review

El Haj M, Antoine P, Amouyel P, Lambert JC, Pasquier F, Kapogiannis D.

Ageing Res Rev. 2016 May;27:15-22. doi: 10.1016/j.arr.2016.02.002. Epub 2016 Feb 11.

Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy

Wattmo C, Minthon L, Wallin ÅK.

Alzheimers Res Ther. 2016 Feb 17;8:7. doi: 10.1186/s13195-016-0174-1.

Measuring Cortical Connectivity in Alzheimer's Disease as a Brain Neural Network Pathology: Toward Clinical Applications

Teipel S, Grothe MJ, Zhou J, Sepulcre J, Dyrba M, Sorg C, Babiloni C.

J Int Neuropsychol Soc. 2016 Feb;22(2):138-63. doi: 10.1017/S1355617715000995.

Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders

Godefroy O, Bakchine S, Verny M, Delabrousse-Mayoux JP, Roussel M, Pere JJ; REFLEX study group:.

J Alzheimers Dis. 2016;51(3):815-25. doi: 10.3233/JAD-150971.

Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease

Sehlin D, Fang XT, Cato L, Antoni G, Lannfelt L, Syvänen S.

Nat Commun. 2016 Feb 19;7:10759. doi: 10.1038/ncomms10759.

Pseudobulbar Affect or Depression in Dementia?

Chang YD, Davis MP, Smith J, Gutgsell T.

J Pain Symptom Manage. 2016 May;51(5):954-8. doi: 10.1016/j.jpainsymman.2015.12.321. Epub 2016 Feb 17.

Cognitive Decline in Presymptomatic Alzheimer Disease

Howieson DB.

JAMA Neurol. 2016 Apr;73(4):384-5. doi: 10.1001/jamaneurol.2015.4993.

Editorial: Translational Alzheimer's Disease Research

Huang Y, Lahiri DK.

Curr Alzheimer Res. 2016;13(3):214. doi: 10.2174/156720501303160217102238.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias